The market

Dual-eligible Americans — people on both Medicare and Medicaid — are roughly 12 million people and represent ~30% of combined federal and state healthcare spending. Within that population, the ~1.5 million living with dementia are the highest-variance cohort: the most expensive, the most operationally complex, and the most neglected by today's care-management playbooks. Their caregivers — also visible to the same payers, also generating cost when they break down — have never been a distinct unit of care.

The dyad of patient + primary caregiver is the actual unit that the healthcare system interacts with, and it's the unit Dyad Health builds for.

"If you only pay attention to the person with dementia, you miss half the reason they end up in the hospital. The caregiver's health drives the patient's outcomes. That's the insight that's been sitting in plain sight for a decade, waiting for a company to be built around it."

Why now

Three macro shifts converge in 2026–2027 to make dyadic care a fundable category:

Dyad is not dependent on any specific policy window — our unit economics hold under today's rules. What the shifts do is compress the sales cycle from 2028 go-lives to 2027 go-lives.

What we do

For a health plan's dementia-plus-caregiver members, Dyad delivers:

Care is delivered through the plan's existing network. We add what's missing; we don't replace what's there.

Team

Founder & CEO

Genevieve Caruncho-Simpson

Ten-plus years at the intersection of dual-eligible health plan strategy, caregiver-focused care design, and value-based-care contracting. Previously led cross-functional programs for California Medi-Cal and Medicare-Medicaid alignment initiatives.

Clinical leadership

Dementia specialist lead

In formation. The clinical leader for Dyad's dementia-specific care oversight, with a contracted advisory bench in behavioral neurology, geriatric psychiatry, and primary-care integration. Announced with the first plan partnership.

Commercial leadership

Plan contracting lead

In formation. Search underway for a commercial lead with direct experience contracting dyadic or dementia programs with Medicare Advantage and D-SNP plans.

Current stage

What we share — and when

Dyad keeps cost, savings, and contract-specific figures out of public materials. Those conversations happen with signed NDAs, typically after a first call. If you're an investor interested in dyadic care, dual-eligible economics, or dementia-specific value-based care — we'd like to hear from you.

Active conversations. Let's have one.

Email Genevieve directly for a first conversation, or reach our general address and we'll route you. We typically respond within 48 hours; faster when the fit is obvious.

Start a conversation → Read the FAQ